PubMed

The efficacy of sertraline for controlling hot flashes in women with or at high risk of developing breast cancer.

Wu MF, Hilsenbeck SG, Tham YL, Kramer R, Elledge RM, Chang JC, Friedman LC.

Breast Cancer Res Treat. 2009 Nov;118(2):369-75. Epub 2009 Jun 3.PMID: 19495957 [PubMed - in process]Related articles

Association of surgery with improved survival in stage IV breast cancer patients.

Blanchard DK, Shetty PB, Hilsenbeck SG, Elledge RM.

Ann Surg. 2008 May;247(5):732-8.PMID: 18438108 [PubMed - indexed for MEDLINE]Related articles

Molecular heterogeneity of inflammatory breast cancer: a hyperproliferative phenotype.

Nguyen DM, Sam K, Tsimelzon A, Li X, Wong H, Mohsin S, Clark GM, Hilsenbeck SG, Elledge RM, Allred DC, O'Connell P, Chang JC.

Clin Cancer Res. 2006 Sep 1;12(17):5047-54.PMID: 16951220 [PubMed - indexed for MEDLINE]Related articlesFree article

The adherence to practice guidelines in the assessment of bone health in women with chemotherapy-induced menopause.

Tham YL, Sexton K, Weiss HL, Elledge RM, Friedman LC, Kramer RM.

J Support Oncol. 2006 Jun;4(6):295-8, 304.PMID: 16805332 [PubMed - indexed for MEDLINE]Related articles

Tales from a targeted therapy.

Elledge RM.

J Clin Oncol. 2006 Mar 20;24(9):1323-5. Epub 2006 Feb 27. No abstract available. PMID: 16505410 [PubMed - indexed for MEDLINE]Related articles

Morphologic and immunophenotypic markers as surrogate endpoints of tamoxifen effect for prevention of breast cancer.

Mohsin SK, Allred DC, Osborne CK, Cruz A, Otto P, Chew H, Clark GM, Elledge RM.

Breast Cancer Res Treat. 2005 Dec;94(3):205-11.PMID: 16267611 [PubMed - indexed for MEDLINE]Related articles

Clinical response to neoadjuvant docetaxel predicts improved outcome in patients with large locally advanced breast cancers.

Tham YL, Gomez LF, Mohsin S, Gutierrez MC, Weiss H, Hilsenbeck SG, Elledge RM, Chamness GC, Osborne CK, Allred DC, Chang JC.

Breast Cancer Res Treat. 2005 Dec;94(3):279-84.PMID: 16261403 [PubMed - indexed for MEDLINE]Related articles

Premalignant and in situ breast disease: biology and clinical implications.

Arpino G, Laucirica R, Elledge RM.

Ann Intern Med. 2005 Sep 20;143(6):446-57.PMID: 16172443 [PubMed - indexed for MEDLINE]Related articlesFree article

Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance.

Arpino G, Weiss H, Lee AV, Schiff R, De Placido S, Osborne CK, Elledge RM.

J Natl Cancer Inst. 2005 Sep 7;97(17):1254-61.PMID: 16145046 [PubMed - indexed for MEDLINE]Related articlesFree article

Fulvestrant versus anastrozole for the treatment of advanced breast carcinoma: a prospectively planned combined survival analysis of two multicenter trials.

Howell A, Pippen J, Elledge RM, Mauriac L, Vergote I, Jones SE, Come SE, Osborne CK, Robertson JF.

Cancer. 2005 Jul 15;104(2):236-9.PMID: 15937908 [PubMed - indexed for MEDLINE]Related articlesFree article

BRCA1 in clinical breast cancer.

Osborne CK, Elledge RM, Brown PH, Hilsenbeck SG.

Breast Dis. 1998 Apr;10(1-2):77-88. No abstract available. PMID: 15687551 [PubMed]Related articles

HER-2 amplification, HER-1 expression, and tamoxifen response in estrogen receptor-positive metastatic breast cancer: a southwest oncology group study.

Arpino G, Green SJ, Allred DC, Lew D, Martino S, Osborne CK, Elledge RM.

Clin Cancer Res. 2004 Sep 1;10(17):5670-6.PMID: 15355892 [PubMed - indexed for MEDLINE]Related articlesFree article

Lobular neoplasia on core-needle biopsy--clinical significance.

Arpino G, Allred DC, Mohsin SK, Weiss HL, Conrow D, Elledge RM.

Cancer. 2004 Jul 15;101(2):242-50.PMID: 15241819 [PubMed - indexed for MEDLINE]Related articlesFree article

Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome.

Arpino G, Bardou VJ, Clark GM, Elledge RM.

Breast Cancer Res. 2004;6(3):R149-56. Epub 2004 Feb 17.PMID: 15084238 [PubMed - indexed for MEDLINE]Related articlesFree article

Neoadjuvant trastuzumab and docetaxel in breast cancer: preliminary results.

Van Pelt AE, Mohsin S, Elledge RM, Hilsenbeck SG, Gutierrez MC, Lucci A Jr, Kalidas M, Granchi T, Scott BG, Allred DC, Chang JC.

Clin Breast Cancer. 2003 Dec;4(5):348-53.PMID: 14715110 [PubMed - indexed for MEDLINE]Related articles

A roundtable discussion of aromatase inhibitors as therapy for breast cancer.

Allred DC, Baum M, Buzdar AU, Carlson RW, Dowsett M, Elledge RM, Gradishar WJ, Grana G, Howell A, Mamounas EP.

Breast J. 2003 May-Jun;9(3):213-22. Review.PMID: 12752630 [PubMed - indexed for MEDLINE]Related articles

Progesterone receptor status significantly improves outcome prediction over estrogen receptor status alone for adjuvant endocrine therapy in two large breast cancer databases.

Bardou VJ, Arpino G, Elledge RM, Osborne CK, Clark GM.

J Clin Oncol. 2003 May 15;21(10):1973-9.PMID: 12743151 [PubMed - indexed for MEDLINE]Related articles

Idoxifene versus tamoxifen: a randomized comparison in postmenopausal patients with metastatic breast cancer.

Arpino G, Nair Krishnan M, Doval Dinesh C, Bardou VJ, Clark GM, Elledge RM.

Ann Oncol. 2003 Feb;14(2):233-41.PMID: 12562650 [PubMed - indexed for MEDLINE]Related articlesFree article

Survival of patients with metastatic breast carcinoma: importance of prognostic markers of the primary tumor.

Chang J, Clark GM, Allred DC, Mohsin S, Chamness G, Elledge RM.

Cancer. 2003 Feb 1;97(3):545-53.PMID: 12548595 [PubMed - indexed for MEDLINE]Related articlesFree article

Adenoid cystic carcinoma of the breast: molecular markers, treatment, and clinical outcome.

Arpino G, Clark GM, Mohsin S, Bardou VJ, Elledge RM.

Cancer. 2002 Apr 15;94(8):2119-27. Review.PMID: 12001107 [PubMed - indexed for MEDLINE]Related articles

Clinical management of women with genomic BRCA1 and BRCA2 mutations.

Chang J, Elledge RM.

Breast Cancer Res Treat. 2001 Sep;69(2):101-13. Review.PMID: 11759816 [PubMed - indexed for MEDLINE]Related articles

Ductal lavage for detection of cellular atypia in women at high risk for breast cancer.

Dooley WC, Ljung BM, Veronesi U, Cazzaniga M, Elledge RM, O'Shaughnessy JA, Kuerer HM, Hung DT, Khan SA, Phillips RF, Ganz PA, Euhus DM, Esserman LJ, Haffty BG, King BL, Kelley MC, Anderson MM, Schmit PJ, Clark RR, Kass FC, Anderson BO, Troyan SL, Arias RD, Quiring JN, Love SM, Page DL, King EB.

J Natl Cancer Inst. 2001 Nov 7;93(21):1624-32.PMID: 11698566 [PubMed - indexed for MEDLINE]Related articlesFree article

Estrogen receptor (ER) and progesterone receptor (PgR), by ligand-binding assay compared with ER, PgR and pS2, by immuno-histochemistry in predicting response to tamoxifen in metastatic breast cancer: a Southwest Oncology Group Study.

Elledge RM, Green S, Pugh R, Allred DC, Clark GM, Hill J, Ravdin P, Martino S, Osborne CK.

Int J Cancer. 2000 Mar 20;89(2):111-7.PMID: 10754487 [PubMed - indexed for MEDLINE]Related articles

RESPONSE: Re: Tumor Characteristics and Clinical Outcome of Elderly Women With Breast Cancer.

Diab SG, Elledge RM, Clark GM.

J Natl Cancer Inst. 2001 Jan 3;93(1):65-66. No abstract available. PMID: 11136847 [PubMed - as supplied by publisher]Related articles

Prognostic value of p53 for local failure in mastectomy-treated breast cancer patients.

Zellars RC, Hilsenbeck SG, Clark GM, Allred DC, Herman TS, Chamness GC, Elledge RM.

J Clin Oncol. 2000 May;18(9):1906-13.PMID: 10784631 [PubMed - indexed for MEDLINE]Related articles

Tumor characteristics and clinical outcome of elderly women with breast cancer.

Diab SG, Elledge RM, Clark GM.

J Natl Cancer Inst. 2000 Apr 5;92(7):550-6.PMID: 10749910 [PubMed - indexed for MEDLINE]Related articlesFree article

Caution concerning micrometastatic breast carcinoma in sentinel lymph nodes.

Allred DC, Elledge RM.

Cancer. 1999 Sep 15;86(6):905-7. No abstract available. PMID: 10491512 [PubMed - indexed for MEDLINE]Related articlesFree article

Tumor characteristics and clinical outcome of tubular and mucinous breast carcinomas.

Diab SG, Clark GM, Osborne CK, Libby A, Allred DC, Elledge RM.

J Clin Oncol. 1999 May;17(5):1442-8.PMID: 10334529 [PubMed - indexed for MEDLINE]Related articles

Prognostic and predictive value of p53 and p21 in breast cancer.

Elledge RM, Allred DC.

Breast Cancer Res Treat. 1998;52(1-3):79-98. Review.PMID: 10066074 [PubMed - indexed for MEDLINE]Related articles

Models for early chemoprevention trials in breast cancer.

Fabian CJ, Kimler BF, Elledge RM, Grizzle WE, Beenken SW, Ward JH.

Hematol Oncol Clin North Am. 1998 Oct;12(5):993-1017. Review.PMID: 9888018 [PubMed - indexed for MEDLINE]Related articles

Heat shock proteins hsp27 and hsp70: lack of correlation with response to tamoxifen and clinical course of disease in estrogen receptor-positive metastatic breast cancer (a Southwest Oncology Group Study).

Ciocca DR, Green S, Elledge RM, Clark GM, Pugh R, Ravdin P, Lew D, Martino S, Osborne CK.

Clin Cancer Res. 1998 May;4(5):1263-6.PMID: 9607585 [PubMed - indexed for MEDLINE]Related articlesFree article

Radiation therapy and survival in breast cancer patients with 10 or more positive axillary lymph nodes treated with mastectomy.

Diab SG, Hilsenbeck SG, de Moor C, Clark GM, Osborne CK, Ravdin PM, Elledge RM.

J Clin Oncol. 1998 May;16(5):1655-60.PMID: 9586875 [PubMed - indexed for MEDLINE]Related articles

HER-2 expression and response to tamoxifen in estrogen receptor-positive breast cancer: a Southwest Oncology Group Study.

Elledge RM, Green S, Ciocca D, Pugh R, Allred DC, Clark GM, Hill J, Ravdin P, O'Sullivan J, Martino S, Osborne CK.

Clin Cancer Res. 1998 Jan;4(1):7-12.PMID: 9516946 [PubMed - indexed for MEDLINE]Related articlesFree article

bcl-2 and apoptosis in lymph node positive breast carcinoma.

Berardo MD, Elledge RM, de Moor C, Clark GM, Osborne CK, Allred DC.

Cancer. 1998 Apr 1;82(7):1296-302.PMID: 9529021 [PubMed - indexed for MEDLINE]Related articlesFree article

Oestrogen receptors and breast cancer.

Elledge RM, Osborne CK.

BMJ. 1997 Jun 28;314(7098):1843-4. No abstract available. PMID: 9224112 [PubMed - indexed for MEDLINE]Related articlesFree article

bcl-2, p53, and response to tamoxifen in estrogen receptor-positive metastatic breast cancer: a Southwest Oncology Group study.

Elledge RM, Green S, Howes L, Clark GM, Berardo M, Allred DC, Pugh R, Ciocca D, Ravdin P, O'Sullivan J, Rivkin S, Martino S, Osborne CK.

J Clin Oncol. 1997 May;15(5):1916-22.PMID: 9164202 [PubMed - indexed for MEDLINE]Related articles

WAF1/CIP1 protein expression in human breast tumors.

Diab SG, Yu YY, Hilsenbeck SG, Allred DC, Elledge RM.

Breast Cancer Res Treat. 1997 Apr;43(2):99-103.PMID: 9131264 [PubMed - indexed for MEDLINE]Related articles

Assessing p53 status in breast cancer prognosis: where should you put the thermometer if you think your p53 is sick?

Elledge RM.

J Natl Cancer Inst. 1996 Feb 21;88(3-4):141-3. No abstract available. PMID: 8632483 [PubMed - indexed for MEDLINE]Related articlesFree article

Life and death by p53.

Elledge RM, Lee WH.

Bioessays. 1995 Nov;17(11):923-30. Review.PMID: 8526886 [PubMed - indexed for MEDLINE]Related articles

p53 mutation and tamoxifen resistance in breast cancer.

Elledge RM, Lock-Lim S, Allred DC, Hilsenbeck SG, Cordner L.

Clin Cancer Res. 1995 Oct;1(10):1203-8.PMID: 9815913 [PubMed - indexed for MEDLINE]Related articlesFree article

Accumulation of p53 protein as a possible predictor of response to adjuvant combination chemotherapy with cyclophosphamide, methotrexate, fluorouracil, and prednisone for breast cancer.

Elledge RM, Gray R, Mansour E, Yu Y, Clark GM, Ravdin P, Osborne CK, Gilchrist K, Davidson NE, Robert N, et al.

J Natl Cancer Inst. 1995 Aug 16;87(16):1254-6. No abstract available. PMID: 7563172 [PubMed - indexed for MEDLINE]Related articles

Rapid in vitro assay for predicting response to fluorouracil in patients with metastatic breast cancer.

Elledge RM, Clark GM, Hon J, Thant M, Belt R, Maguire YP, Brown J, Bartels P, Von Hoff DD.

J Clin Oncol. 1995 Feb;13(2):419-23.PMID: 7844603 [PubMed - indexed for MEDLINE]Related articles

Rising levels of estrogen receptor in breast cancer over 2 decades.

Pujol P, Hilsenbeck SG, Chamness GC, Elledge RM.

Cancer. 1994 Sep 1;74(5):1601-6.PMID: 8062191 [PubMed - indexed for MEDLINE]Related articles

p53 protein accumulation detected by five different antibodies: relationship to prognosis and heat shock protein 70 in breast cancer.

Elledge RM, Clark GM, Fuqua SA, Yu YY, Allred DC.

Cancer Res. 1994 Jul 15;54(14):3752-7.PMID: 8033095 [PubMed - indexed for MEDLINE]Related articlesFree article

Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States.

Elledge RM, Clark GM, Chamness GC, Osborne CK.

J Natl Cancer Inst. 1994 May 4;86(9):705-12.PMID: 7908990 [PubMed - indexed for MEDLINE]Related articles

Evaluation of thymidylate synthase RNA expression by polymerase chain reaction.

Elledge RM, Okuyama N, Fitzgerald SD, Fugua SA.

Mol Cell Probes. 1994 Feb;8(1):67-72.PMID: 8028610 [PubMed - indexed for MEDLINE]Related articles

The p53 tumor suppressor gene in breast cancer.

Elledge RM, Allred DC.

Breast Cancer Res Treat. 1994;32(1):39-47. Review.PMID: 7819584 [PubMed - indexed for MEDLINE]Related articles

Estrogen receptor, progesterone receptor, and HER-2/neu protein in breast cancers from pregnant patients.

Elledge RM, Ciocca DR, Langone G, McGuire WL.

Cancer. 1993 Apr 15;71(8):2499-506.PMID: 8095853 [PubMed - indexed for MEDLINE]Related articles

Prognostic factors and therapeutic decisions in axillary node-negative breast cancer.

Elledge RM, McGuire WL.

Annu Rev Med. 1993;44:201-10. Review.PMID: 8476242 [PubMed - indexed for MEDLINE]Related articles

William L. McGuire Memorial Symposium. The role and prognostic significance of p53 gene alterations in breast cancer.

Elledge RM, Fuqua SA, Clark GM, Pujol P, Allred DC.

Breast Cancer Res Treat. 1993;27(1-2):95-102.PMID: 8260732 [PubMed - indexed for MEDLINE]Related articles